Novo Nordisk faces investor pressure for more details on its next-gen obesity drug CagriSema, after unclear trial results caused a drop in its shares in December.
We use cookies to give you the best possible browsing experience. By continuing to use the website, you consent to the use of cookies. You may withdraw your consent at any time - see our Cookie Policy for further details.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
For further information regarding potential cooperation, please call us or make callback request.
To learn more about Dukascopy Bank Binary Options
/ Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Business Introducer and other trading related information, please call us or make callback request.
For further information regarding potential cooperation, please call us or make callback request.